Clinical trials
Completed Infections trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 9 |
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| GlaxoSmithKline | 5 |
| Centre Hospitalier Universitaire Saint Pierre | 3 |
| Janssen-Cilag International NV | 3 |
| Universitair Ziekenhuis Brussel | 3 |
| University Hospital, Ghent | 3 |
| European Society of Intensive Care Medicine | 2 |
| KU Leuven | 2 |
| Abbott | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infections | 53 |
| HIV Infections | 10 |
| Acquired Immunodeficiency Syndrome | 9 |
| Sepsis | 5 |
| Blast Crisis | 4 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
| Leukemia, Hairy Cell | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myeloid, Accelerated Phase | 4 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.